Functional genomics screens reveal a role for TBC1D24 and SV2B in antibody-dependent enhancement of dengue virus infection

被引:0
|
作者
Belmont, Laura [1 ,2 ]
Contreras, Maya [1 ]
Cartwright-Acar, Catiana H. [1 ]
Marceau, Caleb D. [3 ]
Agrawal, Aditi [3 ]
Levoir, Lisa M. [1 ]
Lubow, Jay [1 ]
Goo, Leslie [1 ]
机构
[1] Fred Hutchinson Canc Ctr, Vaccine & Infect Dis Div, Seattle, WA 98109 USA
[2] Univ Washington, Mol Cellular Biol Grad Program, Seattle, WA USA
[3] Chan Zuckerberg Biohub, San Francisco, CA USA
关键词
CRISPR; dengue virus; antibody-dependent enhancement of infection; LIPID RAFTS; HEMORRHAGIC-FEVER; HOST FACTORS; PROTEIN; DISEASE; RECEPTOR; CELLS; SYNAPTOTAGMIN; PATHOGENESIS; MECHANISMS;
D O I
10.1128/jvi.01582-24
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Under some conditions, dengue virus (DENV) can hijack IgG antibodies to facilitate its uptake into target cells expressing Fc gamma receptors (FcgR)-a process known as antibody-dependent enhancement (ADE) of infection. Beyond a requirement for FcgR, host dependency factors for this unusual IgG-mediated infection route remain unknown. To identify cellular factors exclusively required for ADE, here, we performed CRISPR knockout (KO) screens in an in vitro system poorly permissive to infection in the absence of IgG antibodies. Validating our approach, a top hit was FcgRIIa, which facilitates the binding and internalization of IgG-bound DENV but is not required for canonical infection. Additionally, we identified host factors with no previously described role in DENV infection, including TBC1D24 and SV2B, which have known functions in regulated secretion. Using genetic knockout and trans-complemented cells, we validated a functional requirement for these host factors in ADE assays performed with monoclonal antibodies and polyclonal sera in multiple cell lines and using all four DENV serotypes. We show that knockout of TBC1D24 or SV2B impaired the binding of IgG-DENV complexes to cells without affecting FcgRIIa expression levels. Thus, we identify cellular factors beyond FcgR that promote efficient ADE of DENV infection. Our findings represent a first step toward advancing fundamental knowledge behind the biology of a non-canonical infection route implicated in disease.IMPORTANCEAntibodies can paradoxically enhance rather than inhibit dengue virus (DENV) infection in some cases. To advance knowledge of the functional requirements of antibody-dependent enhancement (ADE) of infection beyond existing descriptive studies, we performed a genome-scale CRISPR knockout (KO) screen in an optimized in vitro system permissive to efficient DENV infection only in the presence of IgG. In addition to FcgRIIa, a known receptor that facilitates IgG-mediated uptake of IgG-bound, but not naked DENV particles, our screens identified TBC1D24 and SV2B, cellular factors with no known role in DENV infection. We validated a functional role for TBC1D24 and SV2B in mediating ADE of all four DENV serotypes in different cell lines and using various antibodies. Thus, we identify cellular factors beyond Fc gamma receptors that promote ADE mechanisms. This study represents a first step toward advancing fundamental knowledge beyond a poorly understood non-canonical viral entry mechanism. Antibodies can paradoxically enhance rather than inhibit dengue virus (DENV) infection in some cases. To advance knowledge of the functional requirements of antibody-dependent enhancement (ADE) of infection beyond existing descriptive studies, we performed a genome-scale CRISPR knockout (KO) screen in an optimized in vitro system permissive to efficient DENV infection only in the presence of IgG. In addition to FcgRIIa, a known receptor that facilitates IgG-mediated uptake of IgG-bound, but not naked DENV particles, our screens identified TBC1D24 and SV2B, cellular factors with no known role in DENV infection. We validated a functional role for TBC1D24 and SV2B in mediating ADE of all four DENV serotypes in different cell lines and using various antibodies. Thus, we identify cellular factors beyond Fc gamma receptors that promote ADE mechanisms. This study represents a first step toward advancing fundamental knowledge beyond a poorly understood non-canonical viral entry mechanism.
引用
收藏
页数:20
相关论文
共 17 条
  • [1] Role of dendritic cells in antibody-dependent enhancement of dengue virus infection
    Boonnak, Kobporn
    Slike, Bonnie M.
    Burgess, Timothy H.
    Mason, Randall M.
    Wu, Shuenn-Jue
    Sun, Peifang
    Porter, Kevin
    Rudiman, Irani Fianza
    Yuwono, Djoko
    Puthavathana, Pilaipan
    Marovich, Mary A.
    JOURNAL OF VIROLOGY, 2008, 82 (08) : 3939 - 3951
  • [2] Molecular Simulations Reveal the Role of Antibody Fine Specificity and Viral Maturation State on Antibody-Dependent Enhancement of Infection in Dengue Virus
    Ripoll, Daniel R.
    Wallqvist, Anders
    Chaudhury, Sidhartha
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2019, 9
  • [3] PROFILES OF ANTIBODY-DEPENDENT ENHANCEMENT OF DENGUE VIRUS TYPE-2 INFECTION
    MORENS, DM
    HALSTEAD, SB
    MARCHETTE, NJ
    MICROBIAL PATHOGENESIS, 1987, 3 (04) : 231 - 237
  • [4] The Role of Autophagy-Mediated Dengue Virus Antibody-Dependent Enhancement Infection of THP-1 Cells
    Jiang, Liming
    Sun, Qiangming
    INTERVIROLOGY, 2020, 63 (1-6) : 57 - 65
  • [5] A fatal case report of antibody-dependent enhancement of dengue virus type 1 following remote Zika virus infection
    Ashley N. Bonheur
    Sarah Thomas
    Sara H. Soshnick
    Emily McGibbon
    Alan P. Dupuis
    Rene Hull
    Sally Slavinski
    Paula E. Del Rosso
    Don Weiss
    Danielle T. Hunt
    Megan E. McCabe
    Amy B. Dean
    Rebecca Folkerth
    Anne M. Laib
    Susan J. Wong
    BMC Infectious Diseases, 21
  • [6] A fatal case report of antibody-dependent enhancement of dengue virus type 1 following remote Zika virus infection
    Bonheur, Ashley N.
    Thomas, Sarah
    Soshnick, Sara H.
    McGibbon, Emily
    Dupuis, Alan P., II
    Hull, Rene
    Slavinski, Sally
    Del Rosso, Paula E.
    Weiss, Don
    Hunt, Danielle T.
    McCabe, Megan E.
    Dean, Amy B.
    Folkerth, Rebecca
    Laib, Anne M.
    Wong, Susan J.
    BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [7] The Role of Antibodies in the Treatment of SARS-CoV-2 Virus Infection, and Evaluating Their Contribution to Antibody-Dependent Enhancement of Infection
    Farouq, Mohammed A. H.
    Acevedo, Reinaldo
    Ferro, Valerie A.
    Mulheran, Paul A.
    Al Qaraghuli, Mohammed M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (11)
  • [8] C1q modulation of antibody-dependent enhancement of dengue virus infection in human myeloid cell lines is dependent on cell type and antibody specificity
    Byrne, Alana B.
    Bonnin, Florencia A.
    Lopez, Eduardo L.
    Polack, Fernando P.
    Talarico, Laura B.
    MICROBES AND INFECTION, 2024, 26 (08)
  • [9] Molecular determinants of dengue virus 2 envelope protein important for virus entry in FcγRIIA-Mediated antibody-dependent enhancement of infection
    Chotiwan, Nunya
    Roehrig, John T.
    Schlesinger, Jacob J.
    Blair, Carol D.
    Huang, Claire Y. -H.
    VIROLOGY, 2014, 456 : 238 - 246
  • [10] Replacement of pr gene with Japanese encephalitis virus pr using reverse genetics reduces antibody-dependent enhancement of dengue virus 2 infection
    Ying Wang
    Lulu Si
    Yayan Luo
    Xiaolan Guo
    Junmei Zhou
    Danyun Fang
    Huijun Yan
    Gucheng Zeng
    Lifang Jiang
    Applied Microbiology and Biotechnology, 2015, 99 : 9685 - 9698